OPT Industries is featured in TechCrunch, highlighting that UK-based LumiraDx has added OPT Instaswab to its approved swabs — the first 3D-printed product to earn that distinction.
“With the ability to print around the clock, the firm also believes it can play a pivotal role in addressing supply chain concerns — a long-time goal for additive manufacturing,” writes Brian Heater for TechCrunch.

OPT Industries is featured in TechCrunch, highlighting that UK-based LumiraDx has added OPT Instaswab to its approved swabs — the first 3D-printed product to earn that distinction.
“With the ability to print around the clock, the firm also believes it can play a pivotal role in addressing supply chain concerns — a long-time goal for additive manufacturing,” writes Brian Heater for TechCrunch.

OPT Industries profiled in 3D Printing Industry, featuring company growth and $15M Series A funding to scale up the development of its novel 3D printing metamaterials and products, such as InstaSwab. It highlights OPT’s RAMP roll-to-roll 3D printing platform, which enables the printing of continuous materials at “unlimited lengths” with micron-level precision. 

“Every market, Ou points out, requires unique textiles and functions, but traditional manufacturing faces challenges at every turn, from the fiber and yarn spinning to assembly and transportation. OPT’s has a single process: a liquid polymer made into a flexible, structured material, which can be customized for the functionality needed.” – IFAI, Advanced Textiles Source.

“InstaSwab by OPT Industries is designed to enable better medical testing” – Dezeen

“OPT Industries certainly has a very different approach to making and using 3D printers, and I’ll be watching carefully to see how they evolve in the future.” – Fabbaloo

“Massachusetts startup OPT Industries is perfecting a 3D-printed nasal swab for COVID-19 tests” – TechCrunch

“A better nasal swab for Covid-19 testing: MIT spinout OPT Industries uses novel additive manufacturing systems to create intricately-designed products.” – MIT News